August 26, 2022 11:14 AM EDT
News Briefing

Small neu­rol­o­gy biotech an­nounces prices its $8M IPO; Vivos put on no­tice af­ter miss­ing fil­ing dead­line

Paul Schloesser

Associate Editor

Small biotech PaxMed­ica de­buted on the Nas­daq Fri­day.
Un­der the tick­er $PXMD, PaxMed­ica is of­fer­ing just over 1.5 mil­lion shares at a price of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

No­vo Nordisk CEO skep­ti­cal of PBM promis­es in Sen­ate hear­ing on weight loss drug prices

FDA ad­comm will re­ex­am­ine ap­proval of check­point in­hibitors in two can­cers based on key bio­mark­er

Sanofi hires Mike Quigley as next chief sci­en­tist, in­ter­nal memo says

Up­dat­ed: Gene ther­a­py mak­er blue­bird bio cuts costs again, lays off staff

Wave rides new Phase 2 DMD da­ta as it sets sights on ac­cel­er­at­ed ap­proval

sponsored

PD­Cs vs. AD­Cs: A New Fron­tier in Tar­get­ed Can­cer Ther­a­pies and the Po­ten­tial for De­vel­op­ment Part­ner­ships

A service from the Financial Times